Join Answer ALS on Tuesday July 31 at 3:00m EST for an important webinar on the project’s progress and how we are using technology to help Answer ALS. We apologize for the short notice, but while our plans were to offer this webinar in August, the opportunity arose where we could schedule Dr. Berry and…
Broadcast in November 2015: Jay Fishman, chairman and chief executive officer of Travelers, who was diagnosed with ALS—known as Lou Gehrig’s disease—joined by Dr. Jeff Rothstein to discuss the fatal illness.
Data & TechnologyHarnessing Big Data with Advanced Analytics Neuromine is one of the world’s most robust and comprehensive ALS data resources, integrating multi-omics, clinical, and cellular datasets, while also linking to coordinating iPSC lines, biosamples, and other large-scale data platforms with analytic tools to maximize discovery and collaboration.
Multi-Omnics AnalysisComprehensive Biological Data Integration Making a comprehensive multi-omics datasets available that integrates genomics, transcriptomics, proteomics, epigenomics, and iPSC-derived motor neuron data that is freely accessible for analysis.
IPS Cells & Motor NeuronsGenerated 1,000 Participant-Derived Cell Lines Learn More about how to access 1,000 iPSC lines through our partners at the Cedars-Sinai Biomanufacturing Center
Clinic & enrollmentLeading Clinics Engaged to Complete Enrollment Enrollment in the Answer ALS program is complete, but you can Learn More about connected programs like Champion Insights, ALS Therapy Development’s ARC Program
